US20010016699A1 - Hemofiltration system - Google Patents

Hemofiltration system Download PDF

Info

Publication number
US20010016699A1
US20010016699A1 US08/800,881 US80088197A US2001016699A1 US 20010016699 A1 US20010016699 A1 US 20010016699A1 US 80088197 A US80088197 A US 80088197A US 2001016699 A1 US2001016699 A1 US 2001016699A1
Authority
US
United States
Prior art keywords
conduit
fluid
blood
patient
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US08/800,881
Other languages
English (en)
Inventor
Jeffrey H. Burbank
Charles D. Finch
James M. Brugger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NxStage Medical Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US08/800,881 priority Critical patent/US20010016699A1/en
Assigned to VASCA, INC. reassignment VASCA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRUGGER, JAMES M., BURBANK, JEFFREY H., FINCH, CHARLES D., JR.
Priority to EP98904867A priority patent/EP0969887B1/de
Priority to PCT/US1998/002035 priority patent/WO1998035710A2/en
Priority to DE69832369T priority patent/DE69832369D1/de
Priority to AU62642/98A priority patent/AU6264298A/en
Priority to JP53579598A priority patent/JP2001511679A/ja
Priority to US09/512,927 priority patent/US6589482B1/en
Priority to US09/513,771 priority patent/US6673314B1/en
Priority to US09/513,915 priority patent/US6595943B1/en
Priority to US09/513,911 priority patent/US6638478B1/en
Priority to US09/513,902 priority patent/US6554789B1/en
Priority to US09/513,910 priority patent/US6830553B1/en
Priority to US09/513,773 priority patent/US6579253B1/en
Priority to US09/512,929 priority patent/US6638477B1/en
Assigned to NXSTAGE MEDICAL, INC. reassignment NXSTAGE MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VASCA, INC.
Priority to PCT/US2000/042386 priority patent/WO2001037900A2/en
Priority to EP00991516A priority patent/EP1235613B1/de
Priority to PCT/US2000/042356 priority patent/WO2001037786A2/en
Priority to PCT/US2000/042355 priority patent/WO2001037899A2/en
Priority to AU32732/01A priority patent/AU3273201A/en
Priority to AU32731/01A priority patent/AU3273101A/en
Priority to JP2001539403A priority patent/JP4416368B2/ja
Priority to US09/865,905 priority patent/US6852090B2/en
Priority to US09/894,236 priority patent/US6955655B2/en
Publication of US20010016699A1 publication Critical patent/US20010016699A1/en
Priority to US10/041,949 priority patent/US6979309B2/en
Priority to US10/649,582 priority patent/US7473238B2/en
Priority to US10/796,898 priority patent/US20050113734A1/en
Priority to US10/796,912 priority patent/US20040243047A1/en
Priority to US10/796,913 priority patent/US7776001B2/en
Priority to US10/796,899 priority patent/US20080306426A9/en
Priority to US10/796,787 priority patent/US7147613B2/en
Priority to US10/797,666 priority patent/US20040243049A1/en
Priority to US10/807,906 priority patent/US7300413B2/en
Priority to US10/808,213 priority patent/US7267658B2/en
Priority to US10/807,907 priority patent/US20040245161A1/en
Priority to US10/808,207 priority patent/US7338460B2/en
Priority to US11/163,773 priority patent/US20060084906A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0208—Subcutaneous access sites for injecting or removing fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
    • A61M1/3448—Substitution rate control as a function of the ultrafiltration rate by mechanically linked pumps in both ultra-filtrate and substitution flow line
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
    • A61M1/3451—Substitution rate control as a function of the ultrafiltration rate the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36225—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit with blood pumping means or components thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3639—Blood pressure control, pressure transducers specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/367—Circuit parts not covered by the preceding subgroups of group A61M1/3621

Definitions

  • the present invention relates generally to man-made apparatus that substitutes for natural kidney function, and more particularly to a compact, easy-to-use hemofiltration system equipped to maintain accurate net fluid volume change in a patient, and designed and constructed to be usable repeatable in a patient's home.
  • hemodialysis Loss of human renal function, for example due to kidney disease, affects hundreds of thousands of people worldwide. In the past, chronic renal failure has meant almost certain death. More recently, renal failure is treatable by kidney transplant and/or less-physiologically traumatic procedures such as hemodialysis or hemofiltration.
  • Existing hemodialysis and hemofiltration systems operate by continuously withdrawing blood from a patient, treating the blood to remove waste, and continuously re-introducing treated blood into the patient. Hemodialysis operates by bringing blood into contact with one side of a semi-permeable membrane while a dialysis solution (dialysate) is brought into contact with the other side of the membrane. Uremic toxins diffuse out of the blood, through the semi-permeable membrane due to concentration gradient across the membrane, and into the dialysate. Hemofiltration operates by passing the blood through a filter to remove waste.
  • the present invention provides a set of techniques and systems for providing treatment to patients in need of renal therapy.
  • the invention involves a method of clearing a patient's blood of uremic toxins.
  • the method involves subjecting a patient in need of renal therapy to a protocol involving continuously removing blood from a patient at a blood flow rate of at least 300 ml/min, at least partially clearing the blood of uremic toxins to create cleared blood, and continuously returning the cleared blood to the patient.
  • the protocol is repeated at least four times in one week.
  • the protocol can be repeated five times, six times, or seven times in one week according to various embodiments, and any of these embodiments can be repeated for two weeks, three weeks, one month, two months, or an extended period of time.
  • the protocol involves renal therapy at a blood flow rate of at least 400 ml/min.
  • the flow rate can be 500 ml/min, 600 ml/min, or 700 ml/min according to another set of embodiments, and any member of this set of embodiments can be combined with any of the above and other embodiments.
  • the method can involve subjecting a patient in need of renal therapy to blood treatment at a flow rate of at least 300 ml/min at least four times per week, or, for example, at least 600 ml/min at least six times per week.
  • the method can involve accessing a patient's vascular systems through a subcutaneous port, removing the blood from the patient, at least partially clearing the blood, and returning cleared blood to the patient, optionally via the same or a different subcutaneous port.
  • the methods and systems of the invention facilitate very high clearance rate treatment.
  • One embodiment involves clearing a patient's blood of uremic toxins via hemofiltration at an effective clearance rate of at least 100 ml/min, preferably at least 200 ml/min.
  • the systems and methods of the invention allow for maintenance of a uremic toxin level in a patient within a convenience and comfort range. That is, because the invention provides a system for convenient in-home hemofiltration therapy, a protocol is facilitated in which a patient's uremic toxins are allowed to reach no more than about 80% of the maximum level compared to thrice-weekly therapy levels, following which the patient's blood is treated to reduce toxins and treatment continues only so long as the blood toxin level is at least 20% of the maximum level compared to thrice-weekly therapy levels. The protocol is repeated at least four times in one week.
  • the invention also provides a self-contained system for clearing a patient's blood of uremic toxins.
  • the system includes a filter having a first side fluidly connectable to a source of a patient's blood and a second side fluidly connectable to a waste receptacle.
  • a reservoir is provided that contains from about four to about 25 liters of infusate, and the reservoir is fluidly connectable to the patient's blood stream.
  • the infusate reservoir can contain from about 4 to about 18 liters, or from about 9 to about 13, or 10 to about 12 liters in preferred, single day embodiments.
  • the invention provides a system for clearing a patient's blood of uremic toxins, including a filter having a first side and a second side, an input conduit in fluid communication with the first side of the filter and fluidly connectable to a patient's blood stream, a return conduit in fluid communication with the first side of the filter for returning cleared blood to the patient's blood stream, a waste receptacle, a waste conduit fluidly connecting the waste receptacle to the second side of the filter, a reservoir containing from about 4 to about 25 liters of infusate, and an infusate conduit fluidly connecting the reservoir to the return conduit.
  • the invention also provides a system including a peristaltic pump, and a fluid conduit passing through the pump and having a portion upstream of the pump. The system includes a valve in the portion of the fluid conduit upstream of the pump.
  • Also provided in accordance with the invention is a method including adjusting the rate of fluid flow through a peristaltic pump by adjusting the resistance to fluid flow upstream of the pump.
  • the invention also provides a method including establishing a flow of fluid through a peristaltic pump from a source of the fluid, and changing the rate of flow of the fluid through the peristaltic pump while the pump operates at a constant speed and the source of fluid remains constant.
  • the invention also provides a method including controlling an amount of a replacement fluid added from a reservoir to a blood stream of a patient in response to a signal generated from comparison of (a) a total amount of unaccumulated waste product removed from the blood stream and the replacement fluid in the reservoir with (b) one of the amount of the accumulated waste product and the replacement fluid in the reservoir.
  • the invention also provides a system including a blood treatment device having an input fluidly connectable to a source of blood drawn from a patient in need of renal treatment, and an output fluidly connectable to a receptacle of blood waste product.
  • the system includes a first scale adapted to determine a first value that is a total amount of the content of the receptacle of blood waste product plus an amount of blood replacement fluid (infusate) in a reservoir.
  • a second scale is provided that is adapted to determine a second value that is at least one of the content of the receptacle of blood waste product or the amount of blood replacement fluid in the reservoir.
  • a microprocessor is provided that is capable of generating a signal indicative of a comparison of the first value and the second value, and a controller is included that is capable of controlling delivery of blood replacement fluid to the patient's blood stream in response to the signal.
  • the invention also provides a method including urging simultaneously the flow of first and second physiological fluids within first and second conduits, respectively, via actuation of a single fluid pump actuator.
  • the fluid pump can be a peristaltic pump.
  • the invention also provides a fluid pump.
  • the pump is constructed and arranged for use with a blood treatment system.
  • the treatment system includes a blood treatment device, a withdrawal conduit arranged to supply a source of blood from a patient in need of renal treatment the treatment device, a return conduit arranged to return treated blood from the treatment device to the patient, a waste product conduit arranged to deliver waste product removed from the blood by the treatment device to a waste outlet, and a replacement fluid conduit arranged to deliver a replacement fluid to the patient.
  • the fluid pump is constructed and arranged to urge fluid to flow within at least two of the withdrawal conduit, the return conduit, the waste product conduit, and the replacement fluid conduit.
  • the fluid pump is constructed and arranged to urge fluid to flow through the withdrawal conduit, the waste product conduit, and the infusate (replacement fluid) conduit.
  • the invention also provides an assembly for use with a blood treatment system.
  • the assembly is removably attachable to the system, and includes a blood filter housing having an inlet, a first outlet, and a second outlet.
  • the assembly includes a pump member having a surface that mates with a pump in the treatment system when the assembly is attached to the treatment system.
  • a withdrawal conduit is provided that is in fluid communication with the filter housing inlet and fluidly connectable to a source of blood from a patient in need of renal treatment.
  • a return conduit is provided in fluid communication with the first filter housing outlet and is fluidly connectable to a conduit for returning the treated blood to the patient.
  • a waste product conduit is provided in fluid communication with the second filter housing outlet. At least two of the withdrawal conduit, the return conduit, and the waste product conduit are arranged proximate the pump member surface such that, when the assembly is attached to the treatment system, the at least two conduits are actuable by the pump.
  • the invention also provides a system including a conduit fluidly connectable to a patient's vascular system, and an ultrasonic sensor responsive to fluid flow in the conduit.
  • the sensor includes an output for delivering a signal indicative of fluid flow rate in conduit.
  • An alarm can be provided, responsive to the signal, that is activated when fluid flow strays outside a predetermined range, and in particular when the fluid flow drops between a predetermined level.
  • the invention also provides a system for clearing a patient's blood of uremic toxins.
  • the system includes a subcutaneous port providing fluid communication with a patient's vascular system, a filter having a first side and a second side, an input conduit in fluid communication with the first side of the filter and fluidly connectable to the subcutaneous port, a return conduit in fluid communication with the first side of the filter for returning cleared blood to the patient's blood stream, a waste receptacle, a waste conduit fluidly connecting the waste receptacle to the second side of the filter, a reservoir containing from about 4 to about 25 liters of infusate, and an infusate conduit fluidly connecting the reservoir to the return conduit.
  • the system is constructed and arranged to continuously clear the blood of uremic toxins to create cleared blood at a blood flow rate of at least 300 ml/min.
  • FIG. 1 is an estimated plot of effective blood clearance (treatment rate) versus blood flow rate for hemodialysis (curve A) and hemofiltration (curve B) systems;
  • FIG. 2 is a suggested plot of blood toxin level versus days in a bi-daily hemodialysis protocol (curve C) and a daily hemofiltration protocol (curve D);
  • FIG. 3 is a schematic illustration of a high flow rate, subcutaneous vascular access port
  • FIG. 4 is a schematic illustration of a hemofiltration system of the invention
  • FIG. 5 is a schematic illustration of a pump arrangement of the invention.
  • FIG. 6 is a partial cross-sectional view through lines 3 - 3 of FIG. 2;
  • FIG. 7 is a schematic illustration of a pump race, filter housing, replacement fluid reservoir, and waste receptacle in accordance with the invention including a device for sensing the flow of replacement fluid from the reservoir;
  • FIG. 8 is a schematic illustration of a blood treatment system of the invention.
  • FIG. 9 is a schematic illustration of a blood treatment system according to another embodiment of the invention.
  • the present invention provides a system for the treatment of blood in patients requiring renal therapy, for example in patients suffering renal failure.
  • the system is constructed to be simple to operate safely in the home and allows for the possibility of safe and convenient daily hemofiltration treatments.
  • the hemofiltration therapy facilitated by the system involves passing blood drawn from a patient through a filter to remove uremic toxins (waste material that is removed physiologically by a healthy kidney), and subsequent re-infusion of the blood into the patient.
  • An infusate, or replacement fluid is added to the blood returned to the patient to at least in part make up for the amount of fluid removed during the filtration process.
  • fluid will be replaced in an amount slightly less than that removed to decrease the overall fluid level in the patient.
  • Hemodialysis involves establishment of a flow of a patient's blood along a first side of a semi-permeable membrane in a first direction, and establishment of a dialysate solution flowing typically in the opposite direction on the opposite side of the membrane.
  • the dialysate has a low concentration (typically zero, initially) of toxins desirably removed from blood, and a concentration gradient of toxin is established across the semi-permeable membrane causing toxins to diffuse across the membrane out of the blood.
  • treatment rate does not increase significantly as blood flow rate adjacent the membrane increases above a certain point.
  • curve A of FIG. 1 representsative of hemodialysis
  • treatment rate increase sharply just above zero flow, but quickly tapers off, that is, diminishes in rate of increase until it reaches an approximate plateau in which any increase in blood flow rate results in very little resultant increase in blood treatment rate.
  • Hemofiltration involves convection of toxins across a membrane, specifically, passage of blood through an ultrafiltration membrane that passes toxins but that restricts the passage of blood cells and other components desirably returned to the patient.
  • the toxins are routed to a waste receptacle, and the blood cells and other components trapped by the filter are returned to the patient's blood stream.
  • the rate of blood treatment is independent of any concentration gradient across the filter, and instead is dependent upon the rate of clearance of the filter, that is, the rate at which blood cells and other filtrate can be removed from the filter and re-introduced into the patient's bloodstream.
  • the clearance rate is, in turn, dependent only upon the flow rate of the patient's blood through the filter. Therefore, as indicated by curve B of FIG. 1 (representative of hemofiltration), as blood flow rate increases in hemofiltration, blood treatment rate increases significantly, especially at particularly high blood flow rates.
  • the 60-120 liters of auxiliary fluid, required in hemodialysis (the dialysate) is not required in hemofiltration.
  • FIG. 1 is representative of generalized trends, and is not intended to be precise.
  • a percutaneous blood flow rate of 420 typically is achievable with a 15 gauge needle through a graft (a subcutaneous polytetrafluoroethylene tube connecting an artery and a vein and serving as a location for access to the vascular system), and a flow rate of 500 can be achieved with a 14 gauge needle through a graft.
  • Access to a patient's vascular system in this manner typically cannot be repeated indefinitely with regularity. Repeated access to a patient's vascular system via a 15 or 14 gauge needle is problematic, and can seriously impact the life of a graft. Needles of this type can “core” grafts, that is, can cut out a portion of a graft.
  • FIG. 2 is a representative plot of a bi-daily patient treatment protocol.
  • FIG. 2 does not represent actual experiments. On day zero, a patient has just undergone renal therapy, and the patient's blood is clear of uremic toxins. Gradually, over the course of the next two days, the level of uremic toxins in the blood increases until treatment at day two.
  • the invention involves identification of hemofiltration as a much more advantageous treatment technique than hemodialysis, assuming greater accessible blood flow rate.
  • Hemofiltration would be especially effective for home therapy (if the technique could be made feasible for use in the home) since the only auxiliary fluid required in hemofiltration is the infusate. Infusate is added only to partially replace waste removed from blood, and is required only in an amount of about 8-10 liters per treatment.
  • Treatment in the home would result in a treatment protocol that, for most patients, would be tolerable on a daily basis. If a treatment protocol could be carried out on a daily basis, then a blood toxin situation such as curve D would result.
  • toxin level is maintained at a level no greater than 80% maximum tolerable level, and need not be driven below level 20%.
  • the patient's blood toxin level increases only to a moderate level (80%) after one day, and treatment need be carried out only to the extent necessary to drive the toxin level to the 20% level, since over the next day the toxin level will rise only to 80%. This is advantageous since extra time and effort required for blood clearance to level 0 is not necessary, and the patient need not experience discomfort associated with toxin levels above 80%.
  • hemodialysis that is carried out in a clinic also requires travel time, set-up, take-down, and other miscellaneous activities that can bring the total time to six hours.
  • travel time set-up, take-down, and other miscellaneous activities that can bring the total time to six hours.
  • time is saved overall.
  • the present invention solves, according to one aspect, the problem associated with high treatment rates for hemofiltration, namely low blood flow rate, by providing a high-flow-rate access port.
  • the port makes feasible hemofiltration at rates that reduce treatment times to those tolerable by patients on a daily basis, and the invention also provides a series of hemofiltration systems for safe, convenient, disposable home use.
  • the high-flow-rate port of the invention allows for safe, repeatable, reliable access to a patient's vascular system at flow rates of up to 600-700 ml/min.
  • the port is described in detail in co-pending, commonly-owned U.S. patent application of Burbank, et al., entitled “Valve Port and Method for Vascular Access”, filed Jan. 21, 1997 and incorporated herein by reference.
  • High flow rate can be facilitated, also, using a “T” apparatus described in co-pending, commonly-owned, U.S. patent application Ser. No. 08/724,948, filed Nov. 20, 1996 by Finch, et al., entitled “Subcutaneously-Implanted Cannula and Method for Arterial Access”, incorporated herein by reference.
  • the port (referring to FIG. 3) facilitates high volume withdrawal and/or return of blood to a patient undergoing extracorporeal blood therapy including hemodialysis, hemofiltration, hemodiafiltration, and the like.
  • the port is implantable subcutaneously and can be accessed by passing a needle through a patient's skin (percutaneously) and into the port.
  • Port device 110 includes an upper shell 118 , a base plate 120 , an internal cylinder 122 , and a vertically reciprocating actuator block 124 disposed within the cylinder 122 .
  • a spring 126 urges the actuator block 124 upwardly relative to the cylinder 122 .
  • a conduit 114 (passing into a vein or artery) is pinched closed between an upper lip 128 which is a portion of the wall of cylinder 122 and a lower lip 130 which is a portion of the actuator block 124 .
  • Proximal end of the conduit 114 is connected to the lower end of a tube 132 which depends into an interior volume of the actuator block 124 .
  • the depending tube 132 provides an axial bore 134 for receiving a needle.
  • a needle is introduced through an opening 136 at the upper end of the axial bore 134 .
  • a pair of balls 140 are disposed in an upper portion of the tube 132 and contained within a circular aperture 142 in the shell 118 on the actuator block 124 as in its raised configuration.
  • a needle When a needle is introduced through opening 136 , it exerts a force on the balls 140 thereby depressing the actuator block 124 downward until the block reaches a lower configuration, causing opposed lips 128 and 132 to open and thereby fluidly connecting conduits 114 and 132 .
  • the balls 140 move radially outwardly into an expanded portion 144 of the aperture 142 , and thus become locked within the expanded region so long as the needle remains in place.
  • the high flow rate access port allows for blood flow rates of at least 300 ml/min, preferably at least 400 ml/min, more preferably at least 420 ml/min. Blood flow rates of at least 500 ml/min, at least 600 ml/min, and even at least 700 ml/min are achievable with the high flow rate access port.
  • the port can be used in conjunction with other components of the invention to provide an overall arrangement that is easy to use by most renal failure patients, is reliable, can be manufactured at relatively low cost, and includes low cost ancillary and disposable apparatus.
  • the setup of the apparatus is very simple. Integrated, pre-primed disposable components clip into place in an intuitive fashion.
  • a reusable unit is provided, and a disposable assembly including a waste receptacle, infusate reservoir, filter, and various conduits is provided that can be connected to the reusable unit by connection of only two conduit connectors.
  • the reusable unit is pre-primed such that connection at the two connectors, followed by actuation of the reusable unit control processor initiates treatment.
  • the system is constructed such that the unit can be actuated by the user by pressing just one button.
  • the system of the invention includes a scale or set of scales adapted to determine the amount of waste product removed from blood, the amount of replacement fluid (infusate) in a replacement fluid reservoir, and/or both, for monitoring the progress of a treatment and/or for accurately controlling the net amount of fluid removed from the patient during the treatment (or added, although this is rarely indicated in a treatment protocol).
  • FIG. 4 is a schematic illustration of a blood treatment system 10 in accordance with the invention.
  • the arrangement of FIG. 4 facilitates a method for clearing a patient's blood of toxins by providing a protocol involving removing blood from the patient at a rate of at least 300 ml/min, at least partially clearing the blood of uremic toxins to create cleared blood, and returning the cleared blood to the patient.
  • the protocol can be carried out at least four times per week.
  • a patient blood withdrawal conduit 12 is connected to the vascular system of a patient 14 at a location 16 which, in preferred embodiments, is high-flow rate valve port 110 .
  • Blood withdrawal conduit 12 is routed through a pump 18 and supplies blood to a blood treatment unit 20 via an inlet port 22 .
  • blood treatment unit 20 is a hemofilter.
  • Treated blood from which waste product has been removed by system 20 , exits treatment unit 20 at outlet 24 and is delivered, via conduit 26 , to the vascular system of patient 14 preferably by way of location 28 which, in preferred embodiments, is a high-flow rate port 110 .
  • An ultrasonic detector 30 can be provided along line 26 between blood purification system 20 and patient 14 to detect any or all of flow rate, air bubbles (foam), and hematocrit.
  • a safety clamp 32 can be provided as well to stop flow if detector 30 indicates the presence of unacceptable levels of air bubbles. Ultrasonic detector 30 and safety clamp 32 can be operably and electronically linked to the treatment controller, described below.
  • Waste product exits unit 20 via port 33 and passes through conduit 34 via an inlet 38 into a waste product receptacle 36 .
  • Conduit 34 passes through a pump 40 .
  • a blood detector 35 can be positioned along conduit 34 to detect any leaks in a filter within blood treatment system 20 .
  • the detector detects red blood cells which, if a filter rupture has occurred, will leak into waste line 34 , rather than being returned to patient 14 .
  • the detector can be controlled by the treatment controller, and operably and electronically linked to a system that stops treatment.
  • An articulated clamp 37 can be positioned along conduit 34 to control, or at least fine tune, the rate of flow through pump 40 . This arrangement is described in greater detail below.
  • a reservoir 42 of a blood replacement fluid, or infusate is fluidly connected to return conduit 26 via a replacement fluid conduit 44 connecting an outlet 46 of reservoir 42 with a connection 48 between conduit 44 and conduit 26 .
  • Conduit 44 passes through a pump 50 .
  • Reservoir 42 need include only that amount of infusate required for a particular treatment. Where a bi-daily (every other day) protocol is indicated, infusate reservoir 42 contains from about 8 to about 24 liters of infusate. Where a daily protocol is indicated, reservoir 42 will contain from about 8 to about 12 liters of infusate. As described below, the infusate reservoir can be sold as a pre-packaged, disposable container including a measured amount of infusate for one treatment.
  • the invention provides a system useful for daily hemofiltration, thus reservoir 42 preferably is packaged containing from about 8 to about 12 liters infusate.
  • a sterile filter 47 is positioned in line 44 between pump 50 and line 26 .
  • Pumps 18 , 40 , and 50 are peristaltic pumps according to preferred embodiments. This is described in more detail below.
  • waste receptacle 36 and blood replacement reservoir 42 each rest upon a scale 52 .
  • a net change in patient vascular system fluid content can be determined and thereby controlled. Since waste removed from the patient is registered as an increase in weight on scale 52 , and replacement fluid introduced into the patient is registered as a decrease in weight on scale 52 , the change in readout of scale 52 is equal to the change in net fluid level within the patient as a result of the treatment.
  • the pump requirements of at least two of pumps 18 , 40 , and 50 are met by a single peristaltic pump, and in a particularly preferred embodiment all three of pumps 18 , 40 , and 50 are one and the same.
  • Peristaltic pumps are known for use with fluids other than physiological fluids, and are commercially available (for example, multi-channel pump 13-874-600, available from Fisher Scientific). This arrangement is illustrated in FIG. 5, which shows a pump 54 (defining all of pumps 18 , 40 , and 50 of FIG. 4 in preferred embodiments) including a pump race 56 and roller mechanism 58 , between which each of blood withdrawal conduit 12 , waste removal conduit 34 , and blood replacement fluid conduit 44 pass.
  • FIG. 5 shows a pump 54 (defining all of pumps 18 , 40 , and 50 of FIG. 4 in preferred embodiments) including a pump race 56 and roller mechanism 58 , between which each of blood withdrawal conduit 12 , waste removal conduit 34 , and blood replacement fluid conduit 44 pass.
  • FIG. 5 shows a pump 54 (defining all of
  • each of conduits 12 , 34 , and 44 has a cross-sectional dimension at pump 54 selected to provide a different flow rate within the respective conduit at a constant pump operation speed. This is illustrated in greater detail in FIG. 6, which is a cross-section through lines 33 of FIG. 5. Conduits 12 , 34 , and 44 each are illustrated in cross-section against interior surface 60 of pump race 56 , also shown in cross-section. For purposes of clarity, roller mechanism 58 is shown detached from conduits 12 , 34 , and 44 .
  • the cross-section of conduit 12 is approximately twice the cross-section of conduit 34 , which is approximately twice the cross-section of conduit 44 in preferred embodiments, thus, rotation of roller mechanism 58 against pump race surface 60 will cause fluid to flow in conduit 12 at a higher flow rate than within conduit 34 , and fluid to flow within conduit 34 at a higher flow rate than within conduit 44 .
  • the cross-sections of the various conduits can be adjusted for desired flow rates. Where the tubing wall thickness differs from conduit to conduit, a stepped pump rate can be provided.
  • auxiliary clamps can be used, for example articulated clamp 37 (FIG. 4). Articulated clamp 37 is illustrated along line 34 in FIG. 5.
  • fine tuning of the flow rate can be controlled manually, or automatically with a feedback mechanism, with clamp 37 .
  • clamp 37 impinges upon line 34 , fluid flow through the clamped conduit is restricted causing pressure drop, thus the cross section of the conduit downstream of the clamp will be reduced slightly due to the negative pressure.
  • the peristaltic pump thus includes at least a first and a second conduit each connected to a source of physiological fluid.
  • at least three conduits driven by the pump are connected to physiological fluid sources.
  • any disposable, single use assembly 62 including a filter housing 64 integrally connected to pump race 56 , along with waste receptacle 36 and infusate reservoir 42 is illustrated.
  • the assembly is movably attachable to a blood treatment system of the invention in a manner such that when attached, pump race 56 is engaged by roller mechanism 58 driven by the system.
  • withdrawal conduit 12 is fluidly connected to the filter housing inlet 22 and return conduit 26 is fluidly connected to filter housing outlet 24 .
  • Waste product conduit 34 is fluidly connected to another filter housing outlet 33 .
  • Withdrawal conduit 12 is fluidly connectable via a connector 78 to the patient's vascular system, i.e., a vein or artery (via the “T” described in application Ser. No. 08/724,948, referenced above).
  • Return conduit 26 is connectable via a connector 80 to the patient's vascular system in the same manner.
  • the connectors 78 and 80 can be connected to a needle or fistula before or after insertion into the patient's vein or artery, optionally via port 110 , described above.
  • Withdrawal conduit 12 and waste conduit 34 are mounted within race 56 such that when assembly 62 is connected to the blood treatment controller, these conduits are engaged by and actuated by roller mechanism 58 .
  • replacement fluid conduit 44 is routed adjacent race surface 60 of race 56 for actuation by roller mechanism 58 when the assembly is attached to the treatment system.
  • waste receptacle 36 and infusate reservoir 42 are irremovably connected via conduits 34 and 44 , respectively, to assembly 62 .
  • assembly 62 including filter housing 64 and pump race 56 , along with waste receptacle 36 , infusate reservoir 42 , and conduits 12 , 26 , 34 , and 44 all form an integral unit that is disposable.
  • the unit is provided with an empty waste receptacle and provided with replacement fluid in reservoir 42 , with lines 44 , 34 , 26 , and 12 optionally being primed.
  • connection of the arrangement to the patient's vascular system via connectors 78 and 80 , respectively, followed by connection of pump member (race) 56 to the treatment controller for actuation by roller mechanism 58 , and unclamping of clamps 84 and 86 , respectively, renders the system ready for use.
  • the system can be detached and the entire assembly 62 , including conduits 12 , 26 , 34 , and 44 , filter housing 64 including a filter, pump race 56 , and waste receptacle 36 and infusate reservoir 42 can be disposed of.
  • a reflective foil member 84 is provided to confirm that replacement fluid flow out of reservoir 82 and through conduit 44 is occurring.
  • a light source and detector 85 irradiates reflective foil member 84 for detection.
  • a variety of sensing mechanisms such as optical sensors, ultrasonic sensors, or other sensors can be used to detect replacement fluid flow.
  • waste receptacle 34 and infusate reservoir 42 are packaged together in a box, for shipment. When the box arrives in the patient's home, the patient need only place the box on a scale, open a lid or other opening in the box and remove the filter, pump race, and other tubing, remove a sterility barrier from each of connectors 78 and 80 , and connect the system to the vascular system as described.
  • any combination, or all, of conduits 12 , 44 , 34 , and 26 can be mounted against race surface 60 of race 56 .
  • withdrawal conduit 12 , replacement fluid conduit 44 , and waste conduit 34 are so mounted.
  • one or both of conduits 44 and 34 are two-part conduits, the two-parts of each conduit joined with connectors such as connectors 78 and 80 .
  • one or both of waste receptacle 80 and replacement fluid reservoir 82 are reusable, and disconnectable from disposable assembly 62 via a connector.
  • an additional clamp is preferably provided on the assembly 62 side of the connector, and the conduit is primed.
  • a blood treatment system 86 including a controller housing 88 containing a microprocessor that controls blood treatment, and that includes one or more displays 90 .
  • a two-button device is shown, including a “start” button 94 and a “stop” button 96 .
  • An alarm light 98 indicates malfunction.
  • Housing 88 also contains a scale, the receiving surface 90 of which, as illustrated, supports a container 92 containing waste receptacle 36 and replacement fluid reservoir 42 (not shown).
  • Assembly 62 including filter housing 64 , pump member (race) 56 , a portion of withdrawal conduit 12 , a portion of return conduit 70 , replacement fluid conduit 44 , and waste fluid conduit 34 is attached to the treatment system via latches 100 .
  • pump roller mechanism 58 which is mounted as an integral part of the blood treatment system, acts to pump fluid through conduits 12 , 34 , and 44 .
  • the microprocessor within housing 88 controls actuation of pump roller mechanism 58 during treatment, and the scale monitors the total weight of the waste receptacle 36 and replacement fluid reservoir 42 .
  • the microprocessor typically will be programmed to allow treatment to progress so long as a gradual net weight gain of the waste receptacle and replacement fluid reservoir is observed. This will correspond to a net fluid loss in a patient, which is desirable. If the weight of the combination of the waste receptacle and replacement fluid reservoir strays outside of that range, alarm light 98 will light, indicating malfunction, and the pump will stop.
  • the system can be set such that a weight change outside of a particular set of boundaries will cause the system to shut down.
  • a blood treatment system 210 according to another aspect of the invention is illustrated.
  • a first scale 212 is provided along with a second scale 214 .
  • Scale 212 rests on a scale surface 216 of scale 114 , thus scale 114 registers the weight of waste receptacle 36 and replacement fluid reservoir 42 , and scale 112 registers only the weight of replacement fluid reservoir 42 .
  • scale 114 will display a net change that equals the difference between replacement fluid consumed and waste product recovered.
  • Scale 112 will display only a change in weight resulting from consumption of replacement fluid.
  • scale 114 which records 300 grams initially and 500 grams finally, operates over a range of only 200 grams. This allows greater precision in scale 14 , and precision is particularly important in measuring the net change in fluid content of the patient during treatment.
  • One scale ( 212 ) is used only to determine that the infusate is being pumped. A high level of accuracy is not required in this determination.
  • FIGS. 4 and 7 a system which is essentially completely disposable with the exception of the system controller and scales (described above), involves a disposable filter and filter housing 20 , disposable pump race 56 , disposable waste receptacle 36 and infusate reservoir 42 , and disposable conduits 12 , 34 , 44 , and 26 .
  • the system can be entirely pre-primed, with the only required assembly by the user, in the home, involving removal of the described system from a package, and attachment of the system, fluidly, at only two locations (connectors 78 and 80 ) to a conduit that establishes fluid communication with the vascular system of the patient via needles to port 110 .
  • connectors 78 and 80 insert directly into high flow rate access port 110 .
  • each of connectors 78 and 80 is fluidly connectable to a fistula set including a needle or other device for insertion into port 110 or to percutaneous catheters.
  • the filter housing 64 /pump race 56 assembly need only be fastened to controller 88 via latches 100 , and the controller can be started simply by pushing button 94 .
  • the filter is reusable (can be regenerated by the user) and can be cleaned between uses, but lines 12 , 34 , 44 , and 26 , and the waste receptacle and infusate reservoir are disposable after one use.
  • the simple two-connector assembly, along with attachment of the filter/pump race assembly to the control unit, requires only the additional insertion of the regenerated filter into the filter housing.
  • the filter housing can have an opening at one end thereof which is removable, allowing the filter to be removed and inserted easily without requirement of any other conduit disconnections or connections.
  • the system can be designed so that the filter can be regenerated while remaining in the filter housing by attachment of regeneration lines to the filter housing and appropriate treatment. Where the filter and filter housing both are removable, conduits 12 and 26 can be removed from the filter housing and disposed, and during the next use new conduits attached.
  • a system for removal of uremic toxins from blood is equipped to accurately measure arterial blood pressure without, at any location in the system, a drip chamber.
  • Drip chambers are used to measure blood pressure, but can be disadvantageous since at high flow rates they can infuse bubbles into the flow of blood, which is problematic. Additionally, drip chambers add cost.
  • ultrasonic blood flow detector 30 can be used to measure arterial blood pressure as follows. The speed of rotation of peristaltic pump 18 will give an indication of blood flow rate, but this indication may be inaccurate (as is known for peristaltic pumps) due to negative pressure.
  • the flow rate provided by ultrasonic sensor 30 is very accurate, however, and comparison of the actual flow rate from sensor 30 with the indicated flow rate of pump 18 , and comparison of the difference between these values, can provide one of ordinary skill in the art with actual pressure in withdrawal conduit 12 which typically is fluidly connected to a patient's artery.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • External Artificial Organs (AREA)
US08/800,881 1997-02-14 1997-02-14 Hemofiltration system Abandoned US20010016699A1 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
US08/800,881 US20010016699A1 (en) 1997-02-14 1997-02-14 Hemofiltration system
EP98904867A EP0969887B1 (de) 1997-02-14 1998-02-05 Hämofiltrationssystem
PCT/US1998/002035 WO1998035710A2 (en) 1997-02-14 1998-02-05 Hemofiltration system
DE69832369T DE69832369D1 (de) 1997-02-14 1998-02-05 Hämofiltrationssystem
AU62642/98A AU6264298A (en) 1997-02-14 1998-02-05 Hemofiltration system
JP53579598A JP2001511679A (ja) 1997-02-14 1998-02-05 血液濾過システム
US09/512,929 US6638477B1 (en) 1997-02-14 2000-02-25 Fluid replacement systems and methods for use in hemofiltration
US09/512,927 US6589482B1 (en) 1997-02-14 2000-02-25 Extracorporeal circuits for performing hemofiltration employing pressure sensing without an air interface
US09/513,771 US6673314B1 (en) 1997-02-14 2000-02-25 Interactive systems and methods for supporting hemofiltration therapies
US09/513,915 US6595943B1 (en) 1997-02-14 2000-02-25 Systems and methods for controlling blood flow and waste fluid removal during hemofiltration
US09/513,911 US6638478B1 (en) 1997-02-14 2000-02-25 Synchronized volumetric fluid balancing systems and methods
US09/513,902 US6554789B1 (en) 1997-02-14 2000-02-25 Layered fluid circuit assemblies and methods for making them
US09/513,910 US6830553B1 (en) 1997-02-14 2000-02-25 Blood treatment systems and methods that maintain sterile extracorporeal processing conditions
US09/513,773 US6579253B1 (en) 1997-02-14 2000-02-25 Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
AU32732/01A AU3273201A (en) 1997-02-14 2000-11-29 Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
AU32731/01A AU3273101A (en) 1997-02-14 2000-11-29 Extracorporeal circuits for performing hemofiltration employing pressure sensingwithout an air interface
PCT/US2000/042356 WO2001037786A2 (en) 1997-02-14 2000-11-29 Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
JP2001539403A JP4416368B2 (ja) 1997-02-14 2000-11-29 カートリッジ内に配置された体外流体流パネルを使用する流体処理装置及び方法
EP00991516A EP1235613B1 (de) 1997-02-14 2000-11-29 Anordnung zur Bearbeitung von Flussigkeiten mittels in einer Kassette orientierter Platten für extrakörperlichen Fluss-Kreislauf
PCT/US2000/042386 WO2001037900A2 (en) 1997-02-14 2000-11-29 Hemofiltration systems and methods that maintain sterile extracorporeal processing conditions
PCT/US2000/042355 WO2001037899A2 (en) 1997-02-14 2000-11-29 Extracorporeal circuits for performing hemofiltration employing pressure sensing without an air interface
US09/865,905 US6852090B2 (en) 1997-02-14 2001-05-24 Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US09/894,236 US6955655B2 (en) 1997-02-14 2001-06-27 Hemofiltration system
US10/041,949 US6979309B2 (en) 1997-02-14 2002-01-07 Systems and methods for performing blood processing and/or fluid exchange procedures
US10/649,582 US7473238B2 (en) 1997-02-14 2003-08-27 Hemofiltration systems and methods that maintain sterile extracorporeal processing conditions
US10/797,666 US20040243049A1 (en) 1997-02-14 2004-03-08 Blood-contactless measurement of arterial pressure
US10/796,787 US7147613B2 (en) 1997-02-14 2004-03-08 Measurement of fluid pressure in a blood treatment device
US10/796,898 US20050113734A1 (en) 1997-02-14 2004-03-08 Network-based extracorporeal blood treatment information system
US10/796,899 US20080306426A9 (en) 1997-02-14 2004-03-08 Blood flow control in a blood treatment device
US10/796,912 US20040243047A1 (en) 1997-02-14 2004-03-08 Single step fluid circuit engagement device and method
US10/796,913 US7776001B2 (en) 1997-02-14 2004-03-08 Registration of fluid circuit components in a blood treatment device
US10/807,906 US7300413B2 (en) 1997-02-14 2004-03-23 Blood processing machine and system using fluid circuit cartridge
US10/808,213 US7267658B2 (en) 1997-02-14 2004-03-23 Renal replacement therapy device for controlling fluid balance of treated patient
US10/807,907 US20040245161A1 (en) 1997-02-14 2004-03-23 Mechanism for mechanically balancing flows of fluids in a blood treatment
US10/808,207 US7338460B2 (en) 1997-02-14 2004-03-23 Blood processing machine fluid circuit cartridge
US11/163,773 US20060084906A1 (en) 1997-02-14 2005-10-31 Systems and methods for performing blood processing and/or fluid exchange procedures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/800,881 US20010016699A1 (en) 1997-02-14 1997-02-14 Hemofiltration system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US45123899A Division 1997-02-14 1999-11-29

Related Child Applications (9)

Application Number Title Priority Date Filing Date
US45123899A Continuation-In-Part 1997-02-14 1999-11-29
US45123899A Division 1997-02-14 1999-11-29
US09/513,773 Continuation-In-Part US6579253B1 (en) 1997-02-14 2000-02-25 Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US09/513,902 Continuation-In-Part US6554789B1 (en) 1997-02-14 2000-02-25 Layered fluid circuit assemblies and methods for making them
US09/513,915 Continuation-In-Part US6595943B1 (en) 1997-02-14 2000-02-25 Systems and methods for controlling blood flow and waste fluid removal during hemofiltration
US09/513,910 Continuation-In-Part US6830553B1 (en) 1997-02-14 2000-02-25 Blood treatment systems and methods that maintain sterile extracorporeal processing conditions
US09/513,911 Continuation-In-Part US6638478B1 (en) 1997-02-14 2000-02-25 Synchronized volumetric fluid balancing systems and methods
US09/894,236 Division US6955655B2 (en) 1997-02-14 2001-06-27 Hemofiltration system
US11/163,773 Continuation-In-Part US20060084906A1 (en) 1997-02-14 2005-10-31 Systems and methods for performing blood processing and/or fluid exchange procedures

Publications (1)

Publication Number Publication Date
US20010016699A1 true US20010016699A1 (en) 2001-08-23

Family

ID=25179621

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/800,881 Abandoned US20010016699A1 (en) 1997-02-14 1997-02-14 Hemofiltration system
US09/894,236 Expired - Lifetime US6955655B2 (en) 1997-02-14 2001-06-27 Hemofiltration system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/894,236 Expired - Lifetime US6955655B2 (en) 1997-02-14 2001-06-27 Hemofiltration system

Country Status (6)

Country Link
US (2) US20010016699A1 (de)
EP (1) EP0969887B1 (de)
JP (1) JP2001511679A (de)
AU (1) AU6264298A (de)
DE (1) DE69832369D1 (de)
WO (1) WO1998035710A2 (de)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152482A1 (en) * 2002-02-14 2003-08-14 O'mahony John J. Method and apparatus for an extracorporeal treatment device to control blood withdrawal and infusion
US20030210390A1 (en) * 2002-05-07 2003-11-13 O'mahony John J. Blood leak detector for extracorporeal treatment system
US20040030277A1 (en) * 2000-11-02 2004-02-12 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US20040039324A1 (en) * 2000-11-27 2004-02-26 Chf Solutions, Inc. Controller for ultrafiltration blood circuit which prevents hypotension by monitoring osmotic pressure in blood
US20040084358A1 (en) * 2001-04-13 2004-05-06 Chf Solutions, Inc. User interface for blood treatment device
US20040195165A1 (en) * 2003-04-04 2004-10-07 Chf Solutions, Inc. Hollow fiber filter for extracorporeal blood circuit
US6887214B1 (en) 2000-09-12 2005-05-03 Chf Solutions, Inc. Blood pump having a disposable blood passage cartridge with integrated pressure sensors
US20050094127A1 (en) * 2003-10-29 2005-05-05 Chf Solutions Inc. Cuvette apparatus and system for measuring optical properties of a liquid such as blood
US6890315B1 (en) 2000-05-23 2005-05-10 Chf Solutions, Inc. Method and apparatus for vein fluid removal in heart failure
US20050256444A1 (en) * 2004-04-26 2005-11-17 Chf Solutions Inc. User interface for blood treatment device
US7004924B1 (en) * 1998-02-11 2006-02-28 Nxstage Medical, Inc. Methods, systems, and kits for the extracorporeal processing of blood
US20080203023A1 (en) * 2002-06-06 2008-08-28 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filtger for infusion systems
US20080230450A1 (en) * 2005-01-07 2008-09-25 Burbank Jeffrey H Filtration System for Preparation of Fluids for Medical Applications
US20090182263A1 (en) * 2006-04-07 2009-07-16 Burbank Jeffrey H Filtration system for preparation of fluids for medical applications
US20090211975A1 (en) * 2003-01-07 2009-08-27 Brugger James M Batch Filtration System for Preparation of Sterile Fluid for Renal Replacement Therapy
US20100087771A1 (en) * 2007-02-15 2010-04-08 Asahi Kasei Kuraray Medical Co., Ltd. Blood purification system
US7776001B2 (en) 1997-02-14 2010-08-17 Nxstage Medical Inc. Registration of fluid circuit components in a blood treatment device
US7780619B2 (en) 1999-11-29 2010-08-24 Nxstage Medical, Inc. Blood treatment apparatus
US8517968B2 (en) 2011-02-25 2013-08-27 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US8743354B2 (en) 2010-09-07 2014-06-03 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
USD725261S1 (en) 2012-02-24 2015-03-24 Fresenius Medical Care Holdings, Inc. Blood flow chamber
US9173988B2 (en) 2010-11-17 2015-11-03 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US9194792B2 (en) 2010-09-07 2015-11-24 Fresenius Medical Care Holdings, Inc. Blood chamber for an optical blood monitoring system
US9370324B2 (en) 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US9603993B2 (en) 2005-03-04 2017-03-28 C. R. Bard, Inc. Access port identification systems and methods
US9603992B2 (en) 2005-03-04 2017-03-28 C. R. Bard, Inc. Access port identification systems and methods
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US9717895B2 (en) 2009-11-17 2017-08-01 C. R. Bard, Inc. Overmolded access port including anchoring and identification features
USD799031S1 (en) 2015-09-09 2017-10-03 Fresenius Medical Care Holdings, Inc. Blood flow chamber with directional arrow
US9801993B2 (en) 2010-11-17 2017-10-31 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US9937337B2 (en) 2005-04-27 2018-04-10 C. R. Bard, Inc. Assemblies for identifying a power injectable access port
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US10052471B2 (en) 2008-11-13 2018-08-21 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US10061899B2 (en) 2008-07-09 2018-08-28 Baxter International Inc. Home therapy machine
US10130746B2 (en) 2003-01-07 2018-11-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US10179230B2 (en) 2005-03-04 2019-01-15 Bard Peripheral Vascular, Inc. Systems and methods for radiographically identifying an access port
US10189727B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
US10347374B2 (en) 2008-10-13 2019-07-09 Baxter Corporation Englewood Medication preparation system
US10646405B2 (en) 2012-10-26 2020-05-12 Baxter Corporation Englewood Work station for medical dose preparation system
US10818387B2 (en) 2014-12-05 2020-10-27 Baxter Corporation Englewood Dose preparation data analytics
US10835659B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
WO2020237228A1 (en) * 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10971257B2 (en) 2012-10-26 2021-04-06 Baxter Corporation Englewood Image acquisition for medical dose preparation system
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
US11495334B2 (en) 2015-06-25 2022-11-08 Gambro Lundia Ab Medical device system and method having a distributed database
US11516183B2 (en) 2016-12-21 2022-11-29 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US11948112B2 (en) 2015-03-03 2024-04-02 Baxter Corporation Engelwood Pharmacy workflow management with integrated alerts

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638477B1 (en) 1997-02-14 2003-10-28 Nxstage Medical, Inc. Fluid replacement systems and methods for use in hemofiltration
US6595943B1 (en) 1997-02-14 2003-07-22 Nxstage Medical, Inc. Systems and methods for controlling blood flow and waste fluid removal during hemofiltration
US6638478B1 (en) 1997-02-14 2003-10-28 Nxstage Medical, Inc. Synchronized volumetric fluid balancing systems and methods
US6579253B1 (en) 1997-02-14 2003-06-17 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US6673314B1 (en) 1997-02-14 2004-01-06 Nxstage Medical, Inc. Interactive systems and methods for supporting hemofiltration therapies
US6830553B1 (en) 1997-02-14 2004-12-14 Nxstage Medical, Inc. Blood treatment systems and methods that maintain sterile extracorporeal processing conditions
WO2001037786A2 (en) 1997-02-14 2001-05-31 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US6554789B1 (en) 1997-02-14 2003-04-29 Nxstage Medical, Inc. Layered fluid circuit assemblies and methods for making them
US6582385B2 (en) 1998-02-19 2003-06-24 Nstage Medical, Inc. Hemofiltration system including ultrafiltrate purification and re-infusion system
DE69940608D1 (de) 1998-07-31 2009-04-30 Nephros Inc Vorrichtung zur effizienten hämodiafiltration
CA2349363A1 (en) 1998-10-30 2000-05-11 Nephros, Inc. Non-isosmotic diafiltration system
US6406631B1 (en) 1999-07-30 2002-06-18 Nephros, Inc. Two stage diafiltration method and apparatus
CA2396853A1 (en) 2000-01-11 2001-07-19 Nephros, Inc. Thermally enhanced dialysis/diafiltration system
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US7311690B2 (en) 2002-02-25 2007-12-25 Novashunt Ag Implantable fluid management system for the removal of excess fluid
JP2006507018A (ja) * 2002-02-25 2006-03-02 ダニエル アール． バーネット， 過剰流体の排液のための小嚢シャント
US7163520B2 (en) * 2002-06-26 2007-01-16 Chf Solutions, Inc. Method and device for removal of radiocontrast media from blood
AU2003249296A1 (en) 2002-07-19 2004-02-09 Baxter Healthcare S.A. Systems and methods for performing peritoneal dialysis
JP3958733B2 (ja) * 2002-11-14 2007-08-15 日機装株式会社 血液浄化装置
WO2004066121A2 (en) * 2003-01-15 2004-08-05 Nxstage Medical Inc. Waste balancing for extracorporeal blood treatment systems
US8235931B2 (en) * 2003-01-15 2012-08-07 Nxstage Medical, Inc. Waste balancing for extracorporeal blood treatment systems
US7988679B2 (en) 2003-03-18 2011-08-02 Navilyst Medical, Inc. Pressure responsive slit valve assembly for a plurality of fluids and uses thereof
US20040213684A1 (en) * 2003-04-24 2004-10-28 Klein Jeffrey A. Infiltration pump having insulated rollers and programmable foot pedal
US7435236B2 (en) * 2003-06-27 2008-10-14 Navilyst Medical, Inc. Pressure actuated valve with improved biasing member
US7252652B2 (en) 2003-08-29 2007-08-07 Boston Scientific Scimed, Inc. Valved catheters including high flow rate catheters
US7258534B2 (en) * 2003-09-22 2007-08-21 Hospira, Inc. Fluid delivery device identification and loading system
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
US8038639B2 (en) 2004-11-04 2011-10-18 Baxter International Inc. Medical fluid system with flexible sheeting disposable unit
US7744553B2 (en) 2003-12-16 2010-06-29 Baxter International Inc. Medical fluid therapy flow control systems and methods
US8187234B2 (en) 2004-01-29 2012-05-29 Navilyst Medical, Inc. Pressure activated safety valve with anti-adherent coating
US9314608B2 (en) 2004-01-29 2016-04-19 Angiodynamics, Inc Pressure activated safety valve with high flow slit
US8034035B2 (en) 2004-01-29 2011-10-11 Navilyst Medical, Inc. Pressure activated safety valve with high flow slit
US9933079B2 (en) 2004-01-29 2018-04-03 Angiodynamics, Inc. Stacked membrane for pressure actuated valve
US7128836B2 (en) * 2004-03-08 2006-10-31 Potito De Paolis Dialysis device
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
CA2579041A1 (en) * 2004-09-07 2006-03-16 Smith & Nephew, Inc. Methods and devices for sterile field transfer
US20100096311A1 (en) * 2004-10-28 2010-04-22 Nxstage Medical, Inc Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
WO2006058153A1 (en) 2004-11-23 2006-06-01 Smith & Nephew, Inc. Composite mixer
US8328768B2 (en) 2005-02-11 2012-12-11 Angiodynamics, Inc Pressure activated safety valve with improved flow characteristics and durability
JP4892843B2 (ja) * 2005-03-04 2012-03-07 東レ株式会社 液体操作装置
US8585660B2 (en) 2006-01-25 2013-11-19 Navilyst Medical, Inc. Valved catheter with power injection bypass
EP2086466B1 (de) 2006-10-31 2017-12-13 Sequana Medical AG Implantierbare fluid-management-vorrichtung zur entfernung von überschüssiger flüssigkeit
JP2010528781A (ja) * 2007-06-06 2010-08-26 ジョージア テック リサーチ コーポレーション 体外膜酸素化療法における精密な持続的血液濾過のための新規な体液管理システム
US8057423B2 (en) 2007-07-05 2011-11-15 Baxter International Inc. Dialysis system having disposable cassette
US8512553B2 (en) 2007-07-05 2013-08-20 Baxter International Inc. Extracorporeal dialysis ready peritoneal dialysis machine
US8475399B2 (en) 2009-02-26 2013-07-02 Fresenius Medical Care Holdings, Inc. Methods and systems for measuring and verifying additives for use in a dialysis machine
US8105487B2 (en) 2007-09-25 2012-01-31 Fresenius Medical Care Holdings, Inc. Manifolds for use in conducting dialysis
US8040493B2 (en) 2007-10-11 2011-10-18 Fresenius Medical Care Holdings, Inc. Thermal flow meter
US8535522B2 (en) 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
US8597505B2 (en) 2007-09-13 2013-12-03 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
US9308307B2 (en) 2007-09-13 2016-04-12 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US9358331B2 (en) 2007-09-13 2016-06-07 Fresenius Medical Care Holdings, Inc. Portable dialysis machine with improved reservoir heating system
US9199022B2 (en) 2008-09-12 2015-12-01 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US8240636B2 (en) 2009-01-12 2012-08-14 Fresenius Medical Care Holdings, Inc. Valve system
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
US9415150B2 (en) 2007-11-09 2016-08-16 Baxter Healthcare S.A. Balanced flow dialysis machine
CA3057806C (en) 2007-11-29 2021-11-23 Fresenius Medical Care Holdings, Inc. System and method for conducting hemodialysis and hemofiltration
US8545426B2 (en) * 2008-02-27 2013-10-01 Fenwal, Inc. System and method for controlling patient fluid balance and/or flow rate for a therapeutic plasma exchange procedure
US8652082B2 (en) * 2008-04-15 2014-02-18 Gambro Lundia Ab Blood treatment apparatus
US8257321B2 (en) 2008-05-21 2012-09-04 Navilyst Medical, Inc. Pressure activated valve for high flow rate and pressure venous access applications
JP5762954B2 (ja) * 2008-06-25 2015-08-12 ジーイー・ヘルスケア・バイオサイエンス・バイオプロセス・コーポレイション 使い捨てフローパスの自動設置法
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US20100051552A1 (en) 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
AU2009302327C1 (en) 2008-10-07 2015-09-10 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
KR101508483B1 (ko) 2008-10-30 2015-04-06 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 모듈화된 휴대용 투석장치
US8337470B2 (en) 2009-01-28 2012-12-25 Angiodynamics, Inc. Three-way valve for power injection in vascular access devices
US8083721B2 (en) 2009-01-29 2011-12-27 Navilyst Medical, Inc. Power injection valve
US8007468B2 (en) 2009-07-13 2011-08-30 Navilyst Medical, Inc. Method to secure an elastic component in a valve
US20110042280A1 (en) * 2009-08-19 2011-02-24 Access Business Group International Llc Bag Path Fluid Filter Assembly
US8753515B2 (en) 2009-12-05 2014-06-17 Home Dialysis Plus, Ltd. Dialysis system with ultrafiltration control
US8501009B2 (en) 2010-06-07 2013-08-06 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
AU2012217696B2 (en) 2011-02-16 2015-11-12 Sequana Medical Nv Apparatus and methods for treating intracorporeal fluid accumulation
AU2012318561B2 (en) 2011-10-07 2017-04-20 Outset Medical, Inc. Heat exchange fluid purification for dialysis system
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
US9895524B2 (en) 2012-07-13 2018-02-20 Angiodynamics, Inc. Fluid bypass device for valved catheters
US9201036B2 (en) 2012-12-21 2015-12-01 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction
US9157786B2 (en) 2012-12-24 2015-10-13 Fresenius Medical Care Holdings, Inc. Load suspension and weighing system for a dialysis machine reservoir
US9433720B2 (en) 2013-03-14 2016-09-06 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US20140263062A1 (en) 2013-03-14 2014-09-18 Fresenius Medical Care Holdings, Inc. Universal portable machine for online hemodiafiltration using regenerated dialysate
US9440017B2 (en) 2013-03-14 2016-09-13 Baxter International Inc. System and method for performing alternative and sequential blood and peritoneal dialysis modalities
DE102013103335A1 (de) * 2013-04-03 2014-10-09 B. Braun Avitum Ag System zur Erfassung eines Zustands einer Dialysatorvorrichtung, und hierfür verwendbare Sensorvorrichtung
US11026362B2 (en) * 2013-08-27 2021-06-08 Amvac Chemical Corporation System and method for treating individual seeds with liquid chemicals during the planting process
US9354640B2 (en) * 2013-11-11 2016-05-31 Fresenius Medical Care Holdings, Inc. Smart actuator for valve
EP3838308A1 (de) 2014-04-29 2021-06-23 Outset Medical, Inc. Dialysesysteme und -verfahren
CN105455848A (zh) * 2014-09-05 2016-04-06 鸿富锦精密工业（深圳）有限公司 具有自动求救功能的可穿戴式装置和自动求救方法
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
WO2017170797A1 (ja) * 2016-03-29 2017-10-05 国立大学法人徳島大学 原液処理装置、ローラーポンプ装置およびバッグの配置方法
US10610678B2 (en) 2016-08-11 2020-04-07 Angiodynamics, Inc. Bi-directional, pressure-actuated medical valve with improved fluid flow control and method of using such
JP7025408B2 (ja) 2016-08-19 2022-02-24 アウトセット・メディカル・インコーポレイテッド 腹膜透析システム及び方法
US10716922B2 (en) 2016-08-26 2020-07-21 Sequana Medical Nv Implantable fluid management system having clog resistant catheters, and methods of using same
EP3504656A1 (de) 2016-08-26 2019-07-03 Sequana Medical AG Systeme und verfahren zur verwaltung und analyse von durch eine implantierbare vorrichtung erzeugten daten
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
CA3064532A1 (en) 2017-05-24 2018-11-29 Sequana Medical Nv Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
WO2021071619A1 (en) * 2019-10-10 2021-04-15 AMVAC Hong Kong Limited System and method for treating individual seeds with liquid chemicals during the planting process

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3774762A (en) * 1971-01-20 1973-11-27 E Lichtenstein Analogue fluid flow programming structures
US3912455A (en) 1971-01-20 1975-10-14 Lichtenstein Eric Stefan Apparatus for clinical laboratory sample collection and automatic sample processing
DE2552304C3 (de) 1975-11-21 1980-02-21 Sartorius Gmbh, 3400 Goettingen Künstliche Niere
JPS5340691A (en) 1976-04-01 1978-04-13 Korufu Fuaundeeshiyon Za Method and apparatus for removing impurities from fluids
US4108574A (en) 1977-01-21 1978-08-22 International Paper Company Apparatus and method for the indirect measurement and control of the flow rate of a liquid in a piping system
GB1537444A (en) 1977-06-28 1978-12-29 Nycotron As Apparatus for regulating and monitoring dialysis of blood in a dialyzer
SE423318B (sv) 1980-06-27 1982-05-03 Gambro Ab Memofiltrationssystem
DE3131075C2 (de) 1981-08-05 1984-01-19 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Vorrichtung zum Reinigen von Blut
DE3213390A1 (de) * 1982-04-10 1983-10-20 Dieter 3000 Hannover Biela Vorrichtung zur bilanzierung des fluessigkeitsaustausches bei haemofiltrationen
EP0100682A1 (de) 1982-08-03 1984-02-15 Peritronic Medical Industries Plc Verfahren und Gerät zur Durchflussmengensteuerung einer Flüssigkeit
US4479760A (en) 1982-12-28 1984-10-30 Baxter Travenol Laboratories, Inc. Actuator apparatus for a prepackaged fluid processing module having pump and valve elements operable in response to applied pressures
US4479761A (en) 1982-12-28 1984-10-30 Baxter Travenol Laboratories, Inc. Actuator apparatus for a prepackaged fluid processing module having pump and valve elements operable in response to externally applied pressures
US4479762A (en) 1982-12-28 1984-10-30 Baxter Travenol Laboratories, Inc. Prepackaged fluid processing module having pump and valve elements operable in response to applied pressures
DE3302804C2 (de) 1983-01-28 1985-03-14 Fresenius AG, 6380 Bad Homburg Vorrichtung zur Entfernung von Wasser aus Blut
DE3313421C2 (de) 1983-04-13 1985-08-08 Fresenius AG, 6380 Bad Homburg Einrichtung zum Regeln der Ultrafiltrationsrate bei Vorrichtungen zum extrakorporalen Reinigen von Blut
US4728433A (en) 1984-02-02 1988-03-01 Cd Medical, Inc. Ultrafiltration regulation by differential weighing
US4661246A (en) * 1984-10-01 1987-04-28 Ash Medical Systems, Inc. Dialysis instrument with dialysate side pump for moving body fluids
DE3444671A1 (de) 1984-12-07 1986-06-12 Fresenius AG, 6380 Bad Homburg Haemodiafiltrationsgeraet
DE3720665A1 (de) 1987-06-23 1989-01-05 Schael Wilfried Vorrichtung zur haemodialyse und haemofiltration
US4892518A (en) * 1987-12-04 1990-01-09 Biocontrol Technology, Inc. Hemodialysis
DE3837498A1 (de) 1988-11-04 1990-05-17 Fresenius Ag Verfahren und vorrichtung zur ultrafiltration bei der haemodialyse
US5041098A (en) * 1989-05-19 1991-08-20 Strato Medical Corporation Vascular access system for extracorporeal treatment of blood
US5330448A (en) 1990-03-08 1994-07-19 Cristina Chu Method and apparatus for medical fluid transfer
US5230702A (en) 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
US5336165A (en) 1991-08-21 1994-08-09 Twardowski Zbylut J Artificial kidney for frequent (daily) Hemodialysis
US5204681A (en) 1991-09-24 1993-04-20 Gordian Holding Corporation Radio frequency automatic identification system
US5581257A (en) 1991-09-24 1996-12-03 Gordian Holding Corporation Radio frequency automatic identification system
US5211849B1 (en) * 1991-10-11 1997-05-27 Childrens Hosp Medical Center Hemofiltration system and method
JPH05116576A (ja) 1991-10-24 1993-05-14 Nippon Seiko Kk エアバツグ
US5419852A (en) 1991-12-02 1995-05-30 Intevep, S.A. Bimodal emulsion and its method of preparation
FR2684879A1 (fr) * 1991-12-11 1993-06-18 Fournier Gilles Systeme d'hemodialyse jetable.
US5919369A (en) 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5536412A (en) * 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5441636A (en) 1993-02-12 1995-08-15 Cobe Laboratories, Inc. Integrated blood treatment fluid module
US5910252A (en) 1993-02-12 1999-06-08 Cobe Laboratories, Inc. Technique for extracorporeal treatment of blood
US5437861A (en) 1993-03-16 1995-08-01 Applied Immune Sciences, Inc. Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
DE4308586C1 (de) 1993-03-18 1994-05-11 Fresenius Ag Hämodialysegerät mit einer Bilanzkammer
SE502222C2 (sv) * 1994-01-17 1995-09-18 Althin Medical Ab Sätt vid dialys
US5597377A (en) 1994-05-06 1997-01-28 Trustees Of Boston University Coronary sinus reperfusion catheter
DE4419593A1 (de) 1994-06-03 1995-12-07 Fresenius Ag Vorrichtung zum Messen des Drucks eines Mediums
DE59507027D1 (de) 1994-07-13 1999-11-18 Fresenius Medical Care De Gmbh Substituataufbereitung bei der Hämofiltration oder Hämodiafiltration
US5704756A (en) 1995-10-11 1998-01-06 Runnerlift Corporation Trailer mounted personal water-craft support structure
DE19546028C2 (de) 1995-12-09 2000-04-27 Fresenius Ag Bilanzierdisposable zum Bilanzieren von Flüssigkeiten für eine medizinische Behandlungsvorrichtung sowie eine medizinische Behandlungsvorrichtung mit einem Systemeinschub zur Aufnahme eines derartigen Bilanzierdisposables
DE19546027C1 (de) 1995-12-09 1997-04-03 Fresenius Ag Vorrichtung zur Entfernung von toxischen Stoffen aus Blut
EP0892664A4 (de) 1996-03-08 1999-09-15 Baxter Research Medical Inc Selektive membran-sorption-techniken zur blutverwertung
US5902336A (en) 1996-10-15 1999-05-11 Mirimedical, Inc. Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
DE19700466A1 (de) 1997-01-09 1998-07-16 Polaschegg Hans Dietrich Dr Einrichtung und Verfahren zur Hämodiafiltration
US6022335A (en) 1998-07-01 2000-02-08 Ramadan; Hossein Implantable hemodialysis triple port assembly

Cited By (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776001B2 (en) 1997-02-14 2010-08-17 Nxstage Medical Inc. Registration of fluid circuit components in a blood treatment device
US7004924B1 (en) * 1998-02-11 2006-02-28 Nxstage Medical, Inc. Methods, systems, and kits for the extracorporeal processing of blood
US7780619B2 (en) 1999-11-29 2010-08-24 Nxstage Medical, Inc. Blood treatment apparatus
US6890315B1 (en) 2000-05-23 2005-05-10 Chf Solutions, Inc. Method and apparatus for vein fluid removal in heart failure
US7311689B2 (en) 2000-05-23 2007-12-25 Chf Solutions, Inc. Method and apparatus for peripheral vein fluid removal in heart failure
US20080097273A1 (en) * 2000-05-23 2008-04-24 Chf Solutions, Inc. Method and apparatus for peripheral vein fluid removal in heart failure
US20110208106A1 (en) * 2000-05-23 2011-08-25 Chf Solutions, Inc. Method and apparatus for ultrafiltration of blood
US9440018B2 (en) 2000-05-23 2016-09-13 Gambro Lundia Ab Method for ultrafiltration of blood
US7935071B2 (en) 2000-05-23 2011-05-03 Chf Solutions, Inc. Method and apparatus for peripheral vein fluid removal in heart failure
US8603021B2 (en) 2000-05-23 2013-12-10 Gambro Uf Solutions, Inc. Method and apparatus for ultrafiltration of blood
US20050197612A1 (en) * 2000-09-12 2005-09-08 Chf Solutions Inc. Blood pump having a disposable blood filter with integrated pressure sensors
US6887214B1 (en) 2000-09-12 2005-05-03 Chf Solutions, Inc. Blood pump having a disposable blood passage cartridge with integrated pressure sensors
US7410473B2 (en) 2000-09-12 2008-08-12 Chf Solutions Inc. Blood pump having a disposable blood filter with integrated pressure sensors
US20090149795A1 (en) * 2000-11-02 2009-06-11 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US7462161B2 (en) 2000-11-02 2008-12-09 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US20050230313A1 (en) * 2000-11-02 2005-10-20 Chf Solutions Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US7674237B2 (en) 2000-11-02 2010-03-09 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US8702638B2 (en) 2000-11-02 2014-04-22 Gambro Uf Solutions, Inc. Method for blood withdrawal and infusion using a pressure controller
US20040030277A1 (en) * 2000-11-02 2004-02-12 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US7955289B2 (en) 2000-11-02 2011-06-07 Chf Solutions, Inc. Method and apparatus for blood withdrawal and infusion using a pressure controller
US7399289B2 (en) 2000-11-27 2008-07-15 Chf Solutions, Inc. Controller for ultrafiltration blood circuit which prevents hypotension by monitoring osmotic pressure in blood
US20040039324A1 (en) * 2000-11-27 2004-02-26 Chf Solutions, Inc. Controller for ultrafiltration blood circuit which prevents hypotension by monitoring osmotic pressure in blood
US20040084358A1 (en) * 2001-04-13 2004-05-06 Chf Solutions, Inc. User interface for blood treatment device
US20070185429A1 (en) * 2001-04-13 2007-08-09 Chf Solutions Inc. Pressure sensor disconnect detection for a blood treatment device
US7647834B2 (en) 2001-04-13 2010-01-19 Chf Solutions Inc. Pressure sensor disconnect detection for a blood treatment device
US6923782B2 (en) 2001-04-13 2005-08-02 Chf Solutions, Inc. User interface for blood treatment device
US7886611B2 (en) 2001-04-13 2011-02-15 Chf Solutions Inc. Pressure sensor disconnect detection for a blood treatment device
US20100175483A1 (en) * 2001-04-13 2010-07-15 Chf Solutions Inc. Pressure sensor disconnect detection for a blood treatment device
US10556062B2 (en) 2002-01-29 2020-02-11 Baxter International Inc. Electronic medication order transfer and processing methods and apparatus
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US20030152482A1 (en) * 2002-02-14 2003-08-14 O'mahony John J. Method and apparatus for an extracorporeal treatment device to control blood withdrawal and infusion
US7540851B2 (en) 2002-02-14 2009-06-02 Chf Solutions, Inc. Method to control blood and filtrate flowing through an extracorporeal device
US6796955B2 (en) 2002-02-14 2004-09-28 Chf Solutions, Inc. Method to control blood and filtrate flowing through an extracorporeal device
US20050004502A1 (en) * 2002-02-14 2005-01-06 Chf Solutions, Inc. Method to control blood and filtrate flowing through an extracorporeal device
US20060012774A1 (en) * 2002-05-07 2006-01-19 Chf Solutions Inc. Blood leak detector for extracorporeal treatment system
US20030210390A1 (en) * 2002-05-07 2003-11-13 O'mahony John J. Blood leak detector for extracorporeal treatment system
US7230687B2 (en) 2002-05-07 2007-06-12 Chf Solutions Inc. Blood leak detector for extracorporeal treatment system
US6947131B2 (en) 2002-05-07 2005-09-20 Chf Solutions, Inc. Blood leak detector for extracorporeal treatment system
US20080203023A1 (en) * 2002-06-06 2008-08-28 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filtger for infusion systems
US8192387B2 (en) 2002-06-06 2012-06-05 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filter for infusion systems
US8545428B2 (en) 2003-01-07 2013-10-01 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US7749393B2 (en) 2003-01-07 2010-07-06 Nxstage Medical, Inc. Batch filtration system for preparation of sterile fluid for renal replacement therapy
US11446417B2 (en) 2003-01-07 2022-09-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US8460558B2 (en) 2003-01-07 2013-06-11 Nxstage Medical, Inc. Batch filtration system for preparation of sterile fluid for renal replacement therapy
US9388059B2 (en) 2003-01-07 2016-07-12 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US20100228177A1 (en) * 2003-01-07 2010-09-09 Brugger James M Batch filtration system for preparation of sterile fluid for renal replacement therapy
US20090211975A1 (en) * 2003-01-07 2009-08-27 Brugger James M Batch Filtration System for Preparation of Sterile Fluid for Renal Replacement Therapy
US8679348B2 (en) 2003-01-07 2014-03-25 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US8202420B2 (en) 2003-01-07 2012-06-19 Nxstage Medical, Inc. Batch filtration system for preparation of sterile fluid for renal replacement therapy
US7976711B2 (en) 2003-01-07 2011-07-12 Nxstage Medical, Inc. Batch filtration system for preparation of sterile fluid for renal replacement therapy
US20110186521A1 (en) * 2003-01-07 2011-08-04 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10420871B2 (en) 2003-01-07 2019-09-24 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10130746B2 (en) 2003-01-07 2018-11-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US7297270B2 (en) 2003-04-04 2007-11-20 Chf Solutions, Inc. Hollow fiber filter for extracorporeal blood circuit
US7410582B2 (en) 2003-04-04 2008-08-12 Chf Solutions Inc. Hollow fiber filter for extracorporeal blood circuit
US20040195165A1 (en) * 2003-04-04 2004-10-07 Chf Solutions, Inc. Hollow fiber filter for extracorporeal blood circuit
US20080060990A1 (en) * 2003-04-04 2008-03-13 Chf Solutions Inc. Hollow fiber filter for extracorporeal blood circuit
US20050094127A1 (en) * 2003-10-29 2005-05-05 Chf Solutions Inc. Cuvette apparatus and system for measuring optical properties of a liquid such as blood
US7671974B2 (en) 2003-10-29 2010-03-02 Chf Solutions Inc. Cuvette apparatus and system for measuring optical properties of a liquid such as blood
US20100076364A1 (en) * 2004-04-26 2010-03-25 Chf Solutions, Inc. User interface for blood treatment device
US20050256444A1 (en) * 2004-04-26 2005-11-17 Chf Solutions Inc. User interface for blood treatment device
US7585286B2 (en) 2004-04-26 2009-09-08 Chf Solutions, Inc. User interface for blood treatment device
US7303540B2 (en) 2004-04-26 2007-12-04 Chf Solutions, Inc. User interface for blood treatment device
US8197432B2 (en) 2004-04-26 2012-06-12 Gambro Uf Solutions, Inc. User interface for blood treatment device
US20080230450A1 (en) * 2005-01-07 2008-09-25 Burbank Jeffrey H Filtration System for Preparation of Fluids for Medical Applications
US11896750B2 (en) 2005-01-07 2024-02-13 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US9700663B2 (en) 2005-01-07 2017-07-11 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10973969B2 (en) 2005-01-07 2021-04-13 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US9603992B2 (en) 2005-03-04 2017-03-28 C. R. Bard, Inc. Access port identification systems and methods
US10238850B2 (en) 2005-03-04 2019-03-26 Bard Peripheral Vascular, Inc. Systems and methods for radiographically identifying an access port
US11077291B2 (en) 2005-03-04 2021-08-03 Bard Peripheral Vascular, Inc. Implantable access port including a sandwiched radiopaque insert
US10905868B2 (en) 2005-03-04 2021-02-02 Bard Peripheral Vascular, Inc. Systems and methods for radiographically identifying an access port
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
US10857340B2 (en) 2005-03-04 2020-12-08 Bard Peripheral Vascular, Inc. Systems and methods for radiographically identifying an access port
US9603993B2 (en) 2005-03-04 2017-03-28 C. R. Bard, Inc. Access port identification systems and methods
US10675401B2 (en) 2005-03-04 2020-06-09 Bard Peripheral Vascular, Inc. Access port identification systems and methods
US10179230B2 (en) 2005-03-04 2019-01-15 Bard Peripheral Vascular, Inc. Systems and methods for radiographically identifying an access port
US10265512B2 (en) 2005-03-04 2019-04-23 Bard Peripheral Vascular, Inc. Implantable access port including a sandwiched radiopaque insert
US9682186B2 (en) 2005-03-04 2017-06-20 C. R. Bard, Inc. Access port identification systems and methods
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
US10661068B2 (en) 2005-04-27 2020-05-26 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US10183157B2 (en) 2005-04-27 2019-01-22 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US10625065B2 (en) 2005-04-27 2020-04-21 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US9937337B2 (en) 2005-04-27 2018-04-10 C. R. Bard, Inc. Assemblies for identifying a power injectable access port
US10780257B2 (en) 2005-04-27 2020-09-22 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US10016585B2 (en) 2005-04-27 2018-07-10 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US10052470B2 (en) 2005-04-27 2018-08-21 Bard Peripheral Vascular, Inc. Assemblies for identifying a power injectable access port
US9636444B2 (en) 2006-04-07 2017-05-02 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10926016B2 (en) 2006-04-07 2021-02-23 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US20090182263A1 (en) * 2006-04-07 2009-07-16 Burbank Jeffrey H Filtration system for preparation of fluids for medical applications
US8469331B2 (en) 2006-04-07 2013-06-25 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US11633527B2 (en) 2006-04-07 2023-04-25 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10556090B2 (en) 2006-11-08 2020-02-11 C. R. Bard, Inc. Resource information key for an insertable medical device
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US10092725B2 (en) 2006-11-08 2018-10-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US8202241B2 (en) * 2007-02-15 2012-06-19 Asahi Kasei Medical Co., Ltd. Blood purification system
US20100087771A1 (en) * 2007-02-15 2010-04-08 Asahi Kasei Kuraray Medical Co., Ltd. Blood purification system
US10086186B2 (en) 2007-11-07 2018-10-02 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US10792485B2 (en) 2007-11-07 2020-10-06 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US11638810B2 (en) 2007-11-07 2023-05-02 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US11311658B2 (en) 2008-07-09 2022-04-26 Baxter International Inc. Dialysis system having adaptive prescription generation
US10068061B2 (en) 2008-07-09 2018-09-04 Baxter International Inc. Home therapy entry, modification, and reporting system
US11918721B2 (en) 2008-07-09 2024-03-05 Baxter International Inc. Dialysis system having adaptive prescription management
US10272190B2 (en) 2008-07-09 2019-04-30 Baxter International Inc. Renal therapy system including a blood pressure monitor
US10095840B2 (en) 2008-07-09 2018-10-09 Baxter International Inc. System and method for performing renal therapy at a home or dwelling of a patient
US10224117B2 (en) 2008-07-09 2019-03-05 Baxter International Inc. Home therapy machine allowing patient device program selection
US10061899B2 (en) 2008-07-09 2018-08-28 Baxter International Inc. Home therapy machine
US10646634B2 (en) 2008-07-09 2020-05-12 Baxter International Inc. Dialysis system and disposable set
US10347374B2 (en) 2008-10-13 2019-07-09 Baxter Corporation Englewood Medication preparation system
US9370324B2 (en) 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system
US10052471B2 (en) 2008-11-13 2018-08-21 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US10773066B2 (en) 2008-11-13 2020-09-15 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US10155101B2 (en) 2009-11-17 2018-12-18 Bard Peripheral Vascular, Inc. Overmolded access port including anchoring and identification features
US11759615B2 (en) 2009-11-17 2023-09-19 Bard Peripheral Vascular, Inc. Overmolded access port including anchoring and identification features
US9717895B2 (en) 2009-11-17 2017-08-01 C. R. Bard, Inc. Overmolded access port including anchoring and identification features
US10912935B2 (en) 2009-11-17 2021-02-09 Bard Peripheral Vascular, Inc. Method for manufacturing a power-injectable access port
US9285305B2 (en) 2010-09-07 2016-03-15 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US8743354B2 (en) 2010-09-07 2014-06-03 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US9194792B2 (en) 2010-09-07 2015-11-24 Fresenius Medical Care Holdings, Inc. Blood chamber for an optical blood monitoring system
US11013846B2 (en) 2010-11-17 2021-05-25 Fresenius Medical Care Holdings, Inc. Controlling data output of a sensor clip assembly for an optical monitoring system
US10471201B2 (en) 2010-11-17 2019-11-12 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US10668204B2 (en) 2010-11-17 2020-06-02 Fresenius Medical Care Holdings, Inc. Remote interfacing with a sensor clip assembly for an optical monitoring system
US9801993B2 (en) 2010-11-17 2017-10-31 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US10179201B2 (en) 2010-11-17 2019-01-15 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US9173988B2 (en) 2010-11-17 2015-11-03 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
US8517968B2 (en) 2011-02-25 2013-08-27 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US10189728B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10947135B2 (en) 2011-12-13 2021-03-16 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10189727B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
USD757934S1 (en) 2012-02-24 2016-05-31 Fresenius Medical Holdings, Inc. Blood flow chamber
USD725261S1 (en) 2012-02-24 2015-03-24 Fresenius Medical Care Holdings, Inc. Blood flow chamber
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US10971257B2 (en) 2012-10-26 2021-04-06 Baxter Corporation Englewood Image acquisition for medical dose preparation system
US10646405B2 (en) 2012-10-26 2020-05-12 Baxter Corporation Englewood Work station for medical dose preparation system
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
US11850341B2 (en) 2014-10-10 2023-12-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11406744B2 (en) 2014-10-10 2022-08-09 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10835658B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10835657B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10835659B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10869958B2 (en) 2014-10-10 2020-12-22 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10818387B2 (en) 2014-12-05 2020-10-27 Baxter Corporation Englewood Dose preparation data analytics
US11948112B2 (en) 2015-03-03 2024-04-02 Baxter Corporation Engelwood Pharmacy workflow management with integrated alerts
US11495334B2 (en) 2015-06-25 2022-11-08 Gambro Lundia Ab Medical device system and method having a distributed database
USD799031S1 (en) 2015-09-09 2017-10-03 Fresenius Medical Care Holdings, Inc. Blood flow chamber with directional arrow
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11607482B2 (en) 2016-07-18 2023-03-21 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11516183B2 (en) 2016-12-21 2022-11-29 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
WO2020237228A1 (en) * 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems

Also Published As

Publication number Publication date
US6955655B2 (en) 2005-10-18
DE69832369D1 (de) 2005-12-22
EP0969887A2 (de) 2000-01-12
EP0969887B1 (de) 2005-11-16
US20010037079A1 (en) 2001-11-01
WO1998035710A2 (en) 1998-08-20
WO1998035710A3 (en) 1998-11-19
AU6264298A (en) 1998-09-08
JP2001511679A (ja) 2001-08-14

Similar Documents

Publication Publication Date Title
US6955655B2 (en) Hemofiltration system
US6280632B1 (en) Device and method for preparation of substitution solution
CA2437090C (en) Method and apparatus for a hemodiafiltration delivery module
US6824524B1 (en) Tubing for the extracorporal purification of the blood and use thereof
US6533747B1 (en) Extracorporeal circuit for peripheral vein fluid removal
US7935071B2 (en) Method and apparatus for peripheral vein fluid removal in heart failure
US5200090A (en) Multiple fluid source isolation, metering and alarm system and method
US5902336A (en) Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
RU2020970C1 (ru) Искусственная почка
US20060009727A1 (en) Method and apparatus for an extracorporeal control of blood glucose
US20060064053A1 (en) Multichannel coordinated infusion system
JPS62233166A (ja) 血液循環処理装置
WO1991015253A2 (en) Multiple fluid source isolation, metering and alarm system and method
KR102515528B1 (ko) 혈액 치료 장치를 제어하기 위한 방법 및 장치
EP1415673B2 (de) Vorrichtung für Hämofiltration
JPWO2008120803A1 (ja) シリンジポンプを備えた持続的血液浄化装置
US20040020852A1 (en) Method and apparatus for calcium profiling in dialysis
JPH06233813A (ja) 血液浄化装置

Legal Events

Date Code Title Description
AS Assignment

Owner name: VASCA, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BURBANK, JEFFREY H.;FINCH, CHARLES D., JR.;BRUGGER, JAMES M.;REEL/FRAME:008581/0993

Effective date: 19970605

AS Assignment

Owner name: NXSTAGE MEDICAL, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VASCA, INC.;REEL/FRAME:011315/0160

Effective date: 20000510

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION